Skip to main content
Clinical Trials/NCT05638178
NCT05638178
Completed
Not Applicable

The Middle Norway Corona Study - Individual and Genetic Risk Factors for COVID-19 Infection.

St. Olavs Hospital5 sites in 1 country223 target enrollmentStarted: May 1, 2020Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
St. Olavs Hospital
Enrollment
223
Locations
5
Primary Endpoint
Predictors of COVID-19 severity

Overview

Brief Summary

CUT COVID is a cohort study establised to collect information on patients hospitalized because or with infection by SARS-CoV-2. The cohort data includes clinical data and biological samples from multiple timepoints during hospitalization, as well as data from a followup consultation 3 months after discharge.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Positive SARS CoV-2 infection

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Predictors of COVID-19 severity

Time Frame: 1 year after inclusion.

Primary aim is to assess predictors of severe COVID disease in children and adults

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
St. Olavs Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials